![[The Latency Arbitrage: CRISPR Point-of-Care Diagnostics and the Disruption of the PCR Monopoly]](https://www.crimaz.com/assets/images/no-image.png)
Featured
[The Latency Arbitrage: CRISPR Point-of-Care Diagnostics and the Disruption of the PCR Monopoly]
[The FDA's approval of the CRISPR-based SHERLOCK-Air point-of-care diagnostic marks the definitive disruption of the centralized PCR laboratory monopo...
Read Full Story →